A phantom model study to identify the most effective manual aspiration thrombectomy for acute deep-vein thrombosis of the lower extremity

2016 ◽  
Vol 71 (4) ◽  
pp. 321-327 ◽  
Author(s):  
S.H. Kwon ◽  
S.-E. Ahn ◽  
J.S. Shin ◽  
H.-C. Youn ◽  
J.-H. Kim ◽  
...  
1991 ◽  
Vol 5 (3) ◽  
pp. 255-260 ◽  
Author(s):  
B. van Ramshorst ◽  
D.A. Legemate ◽  
J.F. Verzijlbergen ◽  
H. Hoeneveld ◽  
B.C. Eikelboom ◽  
...  

2015 ◽  
Vol 18 (4) ◽  
pp. 178 ◽  
Author(s):  
Eyup Serhat Calik ◽  
Ozgur Dag ◽  
Mehmet Ali Kaygin ◽  
Oruc Alper Onk ◽  
Bilgehan Erkut

<strong>Background</strong>: The purpose of this study was to evaluate the efficacy and safety of pharmacomechanical thrombectomy performed by using a rotational thrombectomy device for the treatment of deep vein thrombosis.<br /><strong>Methods</strong>: Between April 2012 and November 2014, 17 patients with acute deep vein thrombosis underwent pharmacomechanical thrombolysis. The thrombectomy device was used in a single-session technique for patients with lower-extremity deep vein thrombosis. After the procedure, the effect of thrombolysis was evaluated in 3 grades venographically. Grade I showed lysis of under 50%, and grade III showed complete lysis. <br /><strong>Results</strong>: Ten patients (58.8%) had an iliofemoral thrombosis and 7 (41.2%) had a femoropopliteal venous thrombosis. At the end of the pharmacomechanical thrombectomy procedure, 12 patients (70%) had complete (grade III) thrombus resolution. Grade I and II lysis were noted in 2 (12%) and 3 (18%) patients, respectively. Additionally, four (23.5%) required an additional lytic infusion as a result of residual thrombi. The overall grade III, II, and I thrombus resolution rates, including the supplemental thrombolysis, were 82.2% (n = 14), 12% (n = 2), and 5.8% (n = 1), respectively. There was no mortality. <br /><strong>Conclusion</strong>: Based on the present data, use of the Cleaner thrombectomy device may prove to be a safe and feasible single-session pharmacomechanical thrombectomy method for the treatment of acute deep vein thrombosis. To prove the effectiveness of this type treatment, a more extensive large-scale studies are needed.


Sign in / Sign up

Export Citation Format

Share Document